250+ investors that invest in your industry and stage
Transportation
Gaming
Community
Proptech
FinTech
Biotech
Climate
Marketplace
Artificial intelligence
Energy
Hardware
Media (entertainment)
EdTech
Consumer
Health Care
Impact
Enterprise
Agriculture (agtech)
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Web3
Publishing
Clean Energy
Sporting Goods
Oil and Gas
B2B
Education
Organic Food
Big Data
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Video Games
Financial Services
Payments
Photography
Celebrity
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Franchise
Blockchain
Legal
Android
Social Impact
Mobile
Google
Construction
Sports
Local
eSports
Enterprise Software
Email
Wellness
Social Network
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Platforms
Biotechnology
Medical Device
Wine And Spirits
Automotive
Crowdfunding
Social
CleanTech
InsurTech
SaaS
Software
Film
Theatre
Life Science
Non Profit
Qatar
New Zealand
United States
South Korea
Germany
Australia
India
United Kingdom
Ireland
Canada
Africa
Asia
LATAM
Europe
Oceania
Middle East
China
South Africa
Singapore
Brazil
Japan
Indonesia
Sri Lanka
Vietnam
Spain
Saudi Arabia
Argentina
Armenia
Austria
Bangladesh
Bahrain
Belarus
Bulgaria
Belgium
Bermuda
Chile
Cameroon
Switzerland
Colombia
Belize
Costa Rica
Denmark
Ecuador
Algeria
Czech Republic
Georgia
Estonia
Egypt
Ghana
Hong Kong
Ethiopia
Gibraltar
Faroe Islands
Greece
Finland
Croatia
France
Hungary
Barbados
Kuwait
Italy
Jersey
Israel
Lebanon
Cambodia
Kenya
Cayman Islands
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Mali
Morocco
Norway
Malaysia
Mexico
Panama
Malta
Mauritius
Peru
Philippines
Nicaragua
Pakistan
Poland
Russian Federation
Romania
Sweden
Rwanda
Serbia
Seychelles
Turkey
Togo
Puerto Rico
Slovenia
Sierra Leone
San Marino
Senegal
Tunisia
Tanzania
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Thailand
Taiwan
Ukraine
Uruguay
Zimbabwe
Venezuela
Portugal
Azerbaijan
Bahamas
Guatemala
Iraq
Iceland
Namibia
Nigeria
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Cyprus
Latvia
Oman
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Medical VC (Venture Capital) Funds in Asia in October 2023

A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Asia. We rank investors based on the number of investments they made in Medical companies from Asia. We update this investor list every month.

Top 50 Medical VC (Venture Capital) Funds in Asia in October 2023

Investor Medical Asia investments
Sequoia Capital China 26
Qiming Venture Partners 19
BioVenture 19
Legend Capital 17
Puhua Capital 16
Marathon Venture Partners 14
Mitsubishi UFJ Capital 13
Legend Star 13
Med-Fine Capital 13
Northern Light Venture Capital 12
IDG Capital 12
Frees Fund 12
Highlight Capital 12
Lilly Asia Ventures 11
Prox Ventures 11
Cowin Venture 11
Keio Innovation Initiative 10
Share Capital 10
SMBC Venture Capital 9
Hillhouse Capital Group 9
Cenova 9
Cowin Capital 9
Trustbridge Partners 9
Gaorong Capital 9
BioTrack Capital 9
Dalton Venture 8
Haibang Capital 8
Taiyu Investment 8
Huagai Capital 7
Oriental Fortune Capital 7
DT Capital Partners 7
CDH Investments 7
Long Hill Capital 7
Nissay Capital 7
Ping An Ventures 7
ZSVC 7
SBCVC 7
ANRI 7
Sherpa Venture Capital 7
LYFE Capital 7
Volcanics Venture 7
Source Code Capital 6
Baidu Ventures 6
Golden Gate Ventures 6
Sinovation Ventures 6
ZhenFund 6
K2VC 6
OrbiMed 6
Sunland Fund 6
CD Capital 6

Get 300+ niche investors in 2 minutes.

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Trusted by 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck
Investor list
Sequoia Capital China
VC Fund · Beijing, Beijing, China · 56 investments in the past 12 months

We help founders build enduring companies.

Show more...

Investment focus

  • Health Care, Biotechnology, Artificial Intelligence
  • Series A, Series B, Series C
  • China, United States, Australia

Portfolio highlights

  • FUE Bioscience — FUE Bioscience is a medical robot R&D business that specializes in microsurgery above the head and neck. It continues to develop a product matrix of fully intelligent, high-precision, and anthropomorphic surgical robots based on the platform of macro-micro-controlled humanoid dual-arm robots.
  • Life Wilderness — Life Wilderness reimagines human-computer interaction and is linked to the transportation and travel industries.
  • Xintu Heterogeneous — Xintu Heterogeneous offers data storage solutions for heterogeneous computing.
Show more investments...

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 59 investments in the past 12 months

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San Francisco Bay Area.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have investedin outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange or Shenzhen Stock Exchange, or through M&A or by other means. There are also over 70 portfolio companies that have achieved unicorn status.

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, United States, Hong Kong

Portfolio highlights

  • Atantares — We are a development stage startup enabling the next generation of precision medicine by fusing biochip and AI technologies.
  • Saints Sages Medical — Saints Sages Medical is engaged in the production and sales of minimally invasive surgical medical devices. They have several energy device products that are widely used in minimally invasive surgery, hepatobiliary surgery, gynecology, urology, thoracic surgery, and other departments. Saints Sages closely monitors clinical needs and develops moreinnovative minimally invasive surgical devices to serve global patients, relying on a professional research and development team and years of the clinical transformation experience.
  • Epigenic Therapeutics — Epigenic Therapeutics is a biotech firm that offers gene editing therapy.
Show more investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 9 investments in the past 12 months

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Series A, Series B, Series C
  • China, United States, Taiwan

Portfolio highlights

  • Xiguang Bio — Xiguang Bio focuses on the production of diagnostic reagents and provides chemiluminescent raw materials and overall system technology solutions.
  • Jiamuyao Medical — Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.
  • Panomic Biomedical Technology — Suzhou Panomic Biomedical Technology Co., Ltd. (BioNovoGene) was founded in Suzhou Industrial Park Bio-Nano Park in 2013. It is a leading high-tech enterprise focusing on metabolomics in China. Since its establishment, it has established a complete metabolomics detection and analysis platform - PanomicTM / Bionovogene, including metabolitepreprocessing platform, high-resolution mass spectrometry analysis platform, and metabolomics data analysis with independent intellectual property rights The system has perfect biomarker discovery capabilities and clinical application capabilities. The company's scientific research team has a rich background, covering biochemistry, bioinformatics, epidemiology and biostatistics, computer science, etc., and has a consultant team composed of top scientists and clinicians.
Show more investments...

Legend Capital
VC Fund · Beijing, Beijing, China · 33 investments in the past 12 months

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • China, United States, South Korea

Portfolio highlights

  • HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
  • Saige Research — Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control. The company provides a deep learning vision inspection platform optimized for the manufacturing industry to solve inspectors' difficulties and increase work efficiency; its technology provides power detection, speed detection, wideversatility, and development convenience.
  • Ligatech Bioscience — Ligatech Bioscience is an intrusive consumables developer specializing in the development and manufacture of medical devices for the field of sports medicine, as well as the development and production of biomedical materials and products. A production line for artificial ligaments and artificial ligament fixation systems has been established. Andprovide users with relevant technical advice and technical services.
Show more investments...

Puhua Capital
VC Fund · Hangzhou, Zhejiang, China · 11 investments in the past 12 months

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Series A, Series B, Angel
  • China, United Kingdom, United States

Portfolio highlights

  • Zozen — Zhuzheng Robotics is a medical robot manufacturer and developer specializing in minimally invasive spinal surgery. It specializes in researching new, intelligent, high-end medical devices with independent intellectual property rights, researching and developing products related to minimally invasive spinal surgery, and providing related services.
  • Cascade — Cascade produces novel medications that target nuclear receptors for treating metabolic disorders and inflammation.
  • Zhejiang Tianneng New Material — Zhejiang Tianneng New Material manufactures batteries as well as recycles, removes, and re-uses old lithium batteries.
Show more investments...

Marathon Venture Partners
VC Fund · Shanghai, Shanghai, China · 7 investments in the past 12 months

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Series A, Series B, Angel
  • China, Hong Kong, United States

Portfolio highlights

  • Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
  • Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
  • Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
Show more investments...

Mitsubishi UFJ Capital
VC Fund · Tokyo, Tokyo, Japan · 9 investments in the past 12 months

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Funding Round, Series B, Series A
  • Japan, United States, China

Portfolio highlights

  • LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
  • CADDi — CADDi is an online ordering platform for manufacturing industry.
  • EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
Show more investments...

Legend Star
VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Series A, Angel, Seed
  • China, United States, France

Portfolio highlights

  • CoJourney — CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection.
  • Carbon Energy Technology — Carbon Energy Technology develops technology for carbon utilization and its commercialization.
  • China Reserve National Energy — China Reserve National Energy is a developer of air energy storage technology. This technology has the advantages of large scale, low cost, long life, clean and pollution-free, unlimited energy storage period, independent of fossil fuels and geographical conditions, etc.
Show more investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 1 investment in the past 12 months

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States

Portfolio highlights

  • Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
  • Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
  • Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.
Show more investments...

Northern Light Venture Capital
VC Fund · Beijing, Beijing, China · 13 investments in the past 12 months

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Show more...

Investment focus

  • Health Care, Medical, Internet
  • Series A, Series B, Seed
  • China, United States, South Korea

Portfolio highlights

  • Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
  • Zhonghui Laser — Zhonghui Laser is an emerging technology company dedicated to the development and manufacture of advanced lasers.
  • Kangpu Biopharmaceuticals, Ltd. — Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.
Show more investments...

IDG Capital
VC Fund · Beijing, Beijing, China · 24 investments in the past 12 months

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

Show more...

Investment focus

  • Software, Internet, E-Commerce
  • Series A, Series B, Series C
  • China, United States, India

Portfolio highlights

  • Infinimos — Infinimos is a Cosmos ecological liquid staking derivatives platform that aims to build a decentralized and democratized ecosystem capable of maximizing staking rewards while retaining liquidity.
  • Xbotspace — Xbotspace is the generative AI middleware startup investigates the implementation and deployment of huge language models.
  • Biotyx Medical — Biotyx Medical manufactures and sells iron-based biodegradable vascular materials and stents.
Show more investments...

Frees Fund
VC Fund · Beijing, Beijing, China · 11 investments in the past 12 months

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Show more...

Investment focus

  • Artificial Intelligence, E-Commerce, Health Care
  • Series A, Seed, Angel
  • China, United States, Singapore

Portfolio highlights

  • Chuguang 3D — Chuguang 3D is a optical micro-nano 3D sensor technology platform that focuses on research and development, and manufacturing of micro-nano-level optical three-dimensional sensing and measurement and testing instruments.
  • Yanming Biology — Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
  • Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Show more investments...

Highlight Capital
VC Fund · Nanjin, Jiangsu, China · 6 investments in the past 12 months

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • China, United States, Portugal

Portfolio highlights

  • Etana — PT Etana Biotechnologies Indonesia (Etana) is an emerging producer of high-quality, affordable and innovative biopharmaceuticals to treat a range of metabolic, autoimmune and other major life-threatening diseases, including cancer. Nathan Tirtana. Legend Capital. UOB Venture Management. Innovent Bio
  • Hongyixin — Hongyixin is an automotive electronic chip developer.
  • Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
Show more investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 21 investments in the past 12 months

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Hong Kong

Portfolio highlights

  • Akura Medical — Akura Medical is developing a next-generation thrombectomy device that aims to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots.
  • Precede Biosciences — Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. Discover how we are helping create a world where medicine is developed more successfully, and every diagnosis is precise and minimally invasive.
  • LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Show more investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Medical, Biotechnology, Health Care
  • Funding Round, Seed, Series A
  • China, United States, United Kingdom

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • VacV Biotech — VacV Biotherapeutics develops an oncolytic virus platform based on the vaccinia virus. The platform genetically modifies the oncolytic virus, which improves its specificity to tumors, reduces neurotoxicity, enhances the therapeutic effect, and greatly increases the production of extracellular enveloped virus (EEV). It has higher safety andefficiency and can be administered by intravenous injection.
  • HROCT LITT Medtech — HROCT LITT Medtech has developed the unique SNP(Smart Needle Probe) needle imaging, assembled as a catheter, which OD is smaller than 1/5 of the traditional invasive OCT catheter, while the depth and resolution are all multiple times of the traditional invasive OCT catheter, achieving 1um level to supply the histopathology needed microimaging.The fiber could be compatible with different kinds of biopsy needles to access the targets, and also could be coupled with a specific laser to achieve OCT situ diagnosis and laser ablation. Its technology provides revolutionary solutions to neurosurgery, interventional pulmonology, neurovascular, nephropathy, mammary gland, cardiac, GI, and other fields.
Show more investments...

Cowin Venture
VC Fund · Beijing, Beijing, China · 8 investments in the past 12 months

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Angel
  • China, United States, Canada

Portfolio highlights

  • Makino micro — Makino Micro is a high-tech enterprise dedicated to the research and development of 4D high-precision imaging radar.
  • Yimai Silicon — Yimai Silicon is a professional R&D and mass production manufacturer of advanced packaging substrate technology.
  • Gongyan Tuoxin — Gongyan Tuoxin is an optoelectronic chip design and development company that focuses on designs and supplies for high-speed optical communications and networking applications, analog and mixed-signal chips
Show more investments...

Keio Innovation Initiative
VC Fund · Tokyo, Tokyo, Japan · 4 investments in the past 12 months

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Funding Round, Seed, Series A
  • Japan

Portfolio highlights

  • Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
  • Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
  • Nanofiber Quantum Technologies — Powering a globally connected quantum future with pioneering nanofiber cavity QED.
Show more investments...

Share Capital
VC Fund · Shenzhen, Guangdong, China

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Series A, Series B, Angel
  • China, United States, Hong Kong

Portfolio highlights

  • Clounix — Clounix manufactures customizable silicon network chips and cloud native software technology solutions.
  • Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.
  • Help Stem Cell Innovations — Help Stem Cell Innovations Co. Ltd. is the first biotechnology company in China to use iPSC-induced pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. Relying on this core technology, Elp Regenerative Medicine is committed to building a national biological sample bank and cell preparation center,leading the frontier of cell therapy, promoting the clinical transformation of regenerative medicine, and solving the clinically unresolvable degenerative and functional impairment diseases. Reshape human health.
Show more investments...

SMBC Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 6 investments in the past 12 months

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Show more...

Investment focus

  • Health Care, Information Technology, Software
  • Funding Round, Series A, Series B
  • Japan, United States, Mexico

Portfolio highlights

  • Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
  • Luup — Luup is an Internet Company.
  • Kyoto Fusioneering — Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors.
Show more investments...

Hillhouse Capital Group
VC Fund · Changyang, Beijing, China · 16 investments in the past 12 months

Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Series B, Series A, Series C
  • China, United States, India

Portfolio highlights

  • Immorna — Immorna specializes in the production of RNA-based therapeutics.
  • Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
  • Deep Vision Intelligence — Deep Vision Intelligence is a developer of embedded machine vision products.
Show more investments...

Cenova
VC Fund · Shanghai, Shanghai, China · 2 investments in the past 12 months

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

Show more...

Investment focus

  • Health Care, Medical, Pharmaceutical
  • Series B, Series A, Series C
  • China, Singapore, United States

Portfolio highlights

  • Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
  • Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.
  • Hunan Yiyi Pharmaceutical Technology — Hunan Yiyi Pharmaceutical Technology
Show more investments...

Cowin Capital
VC Fund · Shenzhen, Guangdong, China · 27 investments in the past 12 months

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

Show more...

Investment focus

  • Manufacturing, Health Care, Software
  • Series A, Series B, Series C
  • China, Hong Kong, United States

Portfolio highlights

  • SIRUN — SIRUN is a provider and operator of Internet of Vehicles system services, alongside a manufacturer of passenger and commercial vehicles.
  • Anpaixin — Anpaixin manufactures thin-film lithium niobite photonic circuits and optical engines.
  • Xungene Therapeutics — Xunjing Biotech creates RNA-targeting small molecule medicines. The company's goal is to create RNA-targeting small molecule therapeutics that target uncommon disorders and malignancies. It employs RNA structure detection and artificial intelligence technology with its own intellectual property rights to design, screen, and evaluate smallmolecule drugs, shorten the R&D cycle in a more efficient and smarter manner, improve development efficiency, and promote faster drug marketing.
Show more investments...

Trustbridge Partners
VC Fund · Boston, Massachusetts, United States · 1 investment in the past 12 months

Trustbridge Partners is a mission-driven growth equity firm founded in 2006 with approximately $8 billion under management.

Show more...

Investment focus

  • Health Care, Education, Medical
  • Series A, Series B, Series C
  • China, United States, United Kingdom

Portfolio highlights

  • G7 — G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc).
  • Future — Get a dedicated coach, personalized training plan and unlimited workouts.
  • Hystar — Hystar is a high tech company specializing in advanced PEM electrolysers for large scale green hydrogen production, that is 100% sustainable.
Show more investments...

Gaorong Capital
VC Fund · Wangjing, Beijing, China · 14 investments in the past 12 months

Investors of Gaorong Capital include world-class sovereign wealth funds, university endowment funds, family foundations, pension funds and fund of funds, as well as successful entrepreneurs, including founders and managements of Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop. They will provide with valuable industry resources,entrepreneurial experience, and global perspectives.

Show more...

Investment focus

  • Software, E-Commerce, Information Technology
  • Series A, Series B, Series C
  • China, United States, Hong Kong

Portfolio highlights

  • MKSEMI — MKSEMI is a low-power ultra-wideband (UWB) company, provides a complete high precision location solution for device OEMs and ODMs.
  • Cholesgen — Cholesgen is a biopharmaceutical company dedicated to developing original innovative drugs. The company focuses on new disease targets based on biochemistry, disease biology, medicinal chemistry, and clinical translational medicine.
  • Lattice Microelectronics — Lattice Microelectronics promote the design and development, module manufacturing and vehicle application of power semiconductors.
Show more investments...

BioTrack Capital
VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months

BioTrack Capital is a China-based investment firm.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Singapore

Portfolio highlights

  • Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
  • Qitan Technology — Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenientinstrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.
Show more investments...

Dalton Venture
VC Fund · Shanghai, Shanghai, China · 7 investments in the past 12 months

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Show more...

Investment focus

  • Health Care, Medical, Medical Device
  • Series A, Series B, Angel
  • China

Portfolio highlights

  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
  • HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
  • Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Show more investments...

Haibang Capital
VC Fund · Hangzhou, Zhejiang, China · 4 investments in the past 12 months

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Angel, Series B
  • China

Portfolio highlights

  • Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
  • LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
  • Zhongzhiwei Technology — Zhongzhiwei Technology is a new generation of artificial intelligence + machine learning-driven network security collaborative operation solution provider
Show more investments...

Taiyu Investment
VC Fund · Beijing, Beijing, China · 3 investments in the past 12 months

Taiyu Investment is an investment firm.

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Series A, Seed, Angel
  • China

Portfolio highlights

  • Immorna — Immorna specializes in the production of RNA-based therapeutics.
  • ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
  • Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
Show more investments...

Huagai Capital
VC Fund · Beijing, Beijing, China · 9 investments in the past 12 months

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Angel
  • China, United States, Hong Kong

Portfolio highlights

  • Leo Summit — Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.
  • Leaf Biotech — Leaf Biotech is a research and development, production and sales of green chemical-related materials and series intermediates. The business produces biomass resources. The focus of the research and development is the bio-based polyester material PEF and important intermediates, as well as the creation of green drugs and intermediates for healthcareproducts.
  • Dingzhi Biotech — Dingzhi Biotech specialized in immunology and animal vaccine development. It focuses on innovative and large varieties in the research of covers poultry, livestock, and pets.
Show more investments...

Oriental Fortune Capital
VC Fund · Shenzhen, Guangdong, China · 18 investments in the past 12 months

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Show more...

Investment focus

  • Software, Information Technology, E-Commerce
  • Series A, Series B, Seed
  • China, United States

Portfolio highlights

  • Microtreat — Microtreat specializes in the research, development, manufacturing, and sale of different high-end industrial application ultra-precision laser equipment, particularly equipment based on infrared, ultraviolet, green light, and ultra-short pulse technology, which is mostly utilized in the field of thin-film solar energy.
  • Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
  • Pinfeng Medical — Pinfeng Medical is a platform firm that integrates independent research and development, manufacturing, marketing, and service to provide high-quality intelligent testing and precise diagnostic solutions to the local and international in vitro diagnostic industries.
Show more investments...

DT Capital Partners
VC Fund · Shanghai, Shanghai, China · 2 investments in the past 12 months

DT Capital Partners is a private equity investment firm that provides growth capital to early and expansion stage companies. They invest in dynamic businesses that have high growth potential, strong management teams, and demonstrated revenue models in both technology-based and traditional industries. DT Capital Partners currently manages overUSD$500 Million in capital across multiple US dollar and RMB funds, and also has a close affiliation with Madrone Capital in the US, the investment entity for members of the Walton family.In addition to funds, the invested company also benefits from their extensive experience in operating capital markets across the country, close relationships with local governments and companies, and synergies with other investment companies.DT Capital Partners was awarded the “Top 10 China's Best Return Venture Capital Institution” in 2016, and the founding partners of Detong Capital, Shao Jun and Tian Lixin. DT Capital Partner was founded in 2006 and is based in Shanghai, China.

Show more...

Investment focus

  • Health Care, Medical, Software
  • Series A, Series B, Series C
  • China, United States, South Korea

Portfolio highlights

  • Parylene — Parylene is a provider of protective coating application solutions
  • CytoNiche — CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated andintelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products.
  • Next Generation Gene Therapeutics — Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world.NGGT was founded in March 2020by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.
Show more investments...

CDH Investments
VC Fund · Kowloon City, Kowloon, Hong Kong · 19 investments in the past 12 months

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Show more...

Investment focus

  • Manufacturing, Biotechnology, Health Care
  • Series A, Series B, Series C
  • China, United States, Canada

Portfolio highlights

  • Frebang — Fulibang is a novel material R&D company. Concentrate on high-end functional nanomaterial research and development, manufacture, and sales. The main products are nanofiber-based particle purification materials, antibacterial air purification materials, electrostatic melt-blown fiber filter materials with high efficiency and low resistance, gaspollutant catalytic decomposition materials, and flexible ceramic nanofiber high-temperature-resistant insulation materials.
  • Formal-Tech — Formal-Tech is an embedded system software company that specializes in the development, production, and sales of high-safety industrial control software and hardware.
  • Jianwang Technology — Jianwang Technology is a high-tech enterprise that specializes in smart energy solutions and is deeply involved in the new energy business. It focuses on the field of power electronics.
Show more investments...

Long Hill Capital
VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months

Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.

Show more...

Investment focus

  • Medical, Health Care, Training
  • Series A, Series B, Angel
  • China, United States

Portfolio highlights

  • Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
  • Oushisheng Technology — Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.
  • Fuxin Technology Innovation — Fuxin Kechuang is a high-tech company that specializes in offering detailed information solutions for the medical and healthcare industries. The business offers creative software solutions and services to a range of healthcare organizations, actively supports the digital transformation of healthcare, and uplifts the medical sector. The company hasgained recognition and has become a partner of big and medium-sized medical institutions and healthcare institutions by relying on its technological research and development power, service capabilities, and ecosystem of medical and health software.
Show more investments...

Nissay Capital
VC Fund · Tokyo, Tokyo, Japan · 1 investment in the past 12 months

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Show more...

Investment focus

  • Health Care, Internet, Medical
  • Funding Round, Seed, Series A
  • Japan, United States

Portfolio highlights

  • Todoker — Todoker is a baggage delivery convenient service providing company.
  • LUCA Science — LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
  • Beer and Tech — Beer and Tech operates a website for the Phalaenopsis or foliage plant HitoHana. Norihisa Morita and Yoshiaki Ito founded it in 2014, with its headquarters in Saitama in Japan.
Show more investments...

Ping An Ventures
VC Fund · Pudong, Shandong, China

Ping An Ventures is a professional VC under Ping An Insurance (Group) Company of China, Ltd. with focused interest in start-ups of emerging innovation. It is committed to growing with the partners and driving success by provision of both funds and managerial expertise, resources and a platform."

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Angel
  • China, United States, Israel

Portfolio highlights

  • Xiaoqule — Xiaoqule (Happy Community) is a Chinese community-focused e-commerce platform. It is a subsidiary of Gejia.Xiaoqule helps local businesses provide cost-effective products and services to the local community. On the platform, the consumer can order food such as seasonal fruits and vegetables from local businesses. Xiaoqule connects localbusinesses with local consumers, which shortens transportation time and maintains quality of goods. Xiaoqule also serves as a logistical company, providing transportation, technology, marketing and customer support.
  • Zhangshang Tangyi — Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
  • Xgene Pharmaceutical — Xgene Pharmaceutical is a pharmaceutical company.
Show more investments...

ZSVC
VC Fund · Beijing, Beijing, China · 6 investments in the past 12 months

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

Show more...

Investment focus

  • Health Care, Manufacturing, Medical
  • Series A, Series B, Angel
  • China, United States

Portfolio highlights

  • Evolusia — Evolusia is Justice
  • Pin Point — Pin Point is a high-tech company specializing in the research and development of high-precision positioning system products and solutions.
  • Yugong Hi-Tech — Yugong Hi-Tech is a battery cell vacuum drying equipment research and development supplier. It focuses on battery drying and is the industry's first non-contact vacuum drying solution. The company offers non-contact drying solutions for cylinders, soft packages, and square shells.
Show more investments...

SBCVC
VC Fund · Shanghai, Shanghai, China · 2 investments in the past 12 months

Established in 2000, SB China Capital (SBCVC) is a leading venture capital and private equity firm that manages both USD and RMB funds. Their investment focuses on high-tech, high growth companies in TMT, clean technology, healthcare, consumer/retail, and advanced manufacturing sectors; and they invest across all stages of companies.Withextensive entrepreneurial and operating experiences, their professional and seasoned deal team members recognize the vision and champion the ideas of start-up companies. In addition to providing capital support, they help their portfolio companies realize their strategic and commercial potential by giving value-adding services and advices including planning, business development, recruiting and resources deployment.They have a proven track record and solid reputation in identifying high potential start-ups and creating successful industry-leading companies. Some of their spotlight portfolio companies are Alibaba, Taobao, Focus Media, GDS, BGI, Ankon, Di’an, and Edan.With their operational headquarters located in Shanghai and regional offices spread in Beijing, Shenzhen, Chengdu, Hangzhou and Taiwan, they have an extensive coverage of the greater China region and access to potential investment opportunities.

Show more...

Investment focus

  • Health Care, Software, Information Technology
  • Series B, Series A, Series C
  • China, United States, Australia

Portfolio highlights

  • HaploX Biotechnology — HaploX Biotechnology is a Shenzhen-based genetic sequencing company.
  • Shengyin Optoelectronics — Shengyin Optoelectronics is a platform-based micro-nano manufacturing firm that creates ornamental films for electrical appliances and portable electronics.
  • Xindi Digital Engineering System — Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.
Show more investments...

ANRI
VC Fund · Tokyo, Tokyo, Japan · 10 investments in the past 12 months

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

Show more...

Investment focus

  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • Japan, United States, India

Portfolio highlights

  • EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
  • YourTrade — YourTrade helps cross-border e-commerce companies to resale rejected goods and backlogged inventory from overseas sales through local sales channels.It also provides services such as collection and inspection of returned items, as well as resale through local sales channels.
  • Carnot — LLM, Autonomous Agent
Show more investments...

Sherpa Venture Capital
VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Kenya

Portfolio highlights

  • New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
  • Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
  • Danking Pharmaceuticals — Danking Medicine is an innovation-driven drug developer.
Show more investments...

LYFE Capital
VC Fund · Shanghai, Shanghai, China · 6 investments in the past 12 months

In our inaugural fund, we are only seeking biotechnology, pharmaceutical, medical device, diagnostic, healthcare service and digital health companies with an established product foundation but need a bit more capital to accelerate its growth in Greater China. During this critical time, we work closely with our portfolio companies and support theirneeds not only by providing capital but with market planning, talent acquisition, global expansion and global partnership support.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • China, United States, France

Portfolio highlights

  • Noah Medical — Noah Medical is a manufacturer of medical robotic devices used to diagnose and treat patients in a variety of settings. The company's devices perform early diagnoses and treatments in advanced clinical settings, allowing hospitals to treat patients earlier and save lives while leaving only minor scars.
  • HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
  • Genepoint Biological Technology — Genepoint Biological Technology is a healthcare Company.
Show more investments...

Volcanics Venture
VC Fund · Changning, Shanghai, China · 1 investment in the past 12 months

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

Show more...

Investment focus

  • Health Care, Biotechnology, Software
  • Series A, Series B, Seed
  • China, United States

Portfolio highlights

  • Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
  • Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
  • Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
Show more investments...

Source Code Capital
VC Fund · Chaoyang, Liaoning, China · 19 investments in the past 12 months

Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.

Show more...

Investment focus

  • Software, E-Commerce, Artificial Intelligence
  • Series B, Series A, Series C
  • China, United States, Spain

Portfolio highlights

  • Legendsemi — Legendsemi focuses on the development and design of high-performance analog and mixed-signal chips.
  • Minghao Technology — Minghao Technology is a comprehensive solution provider for optometry.
  • Unisun Energy Group — Unisun Energy is a globalized photovoltaic technology solution provider, Unisun's eminent services rely on its effecient cost control, professional technology team, abundant project and financial resources, front-edge data analysis and reassuring O&M.
Show more investments...

Baidu Ventures
VC Fund · Beijing, Beijing, China · 11 investments in the past 12 months

"BV is an independent venture fund established by Baidu in 2017. BV's investors include Baidu as well as other leading financial institutions and businesses. BV currently manages roughly $500M USD across 3 funds and has offices in Beijing and San Francisco. Its mission is to support entrepreneurs and companies who are spearheading the newage of artificial intelligence. These companies are changing the way we work and live—and ultimately how we interact."

Show more...

Investment focus

  • Artificial Intelligence, Health Care, Biotechnology
  • Series A, Seed, Series B
  • China, United States, Germany

Portfolio highlights

  • Sondit — Sondit specializes in R&D and manufacturing of civilian radar systems. It includes intelligent transportation, intelligent security, vehicle-road coordination, and other fields. It engaged in traffic information monitoring and urban traffic management in the field of the intelligent transportation industry.
  • Smartnvy — Smartnvy specializes in the design and development of MRAM and associated devices. Smartnvy employs an ultra-low power design platform adapted to MRAM technology, in conjunction with full-process design methodology.
  • Shengshu Technology — Shengshu Technology is an artificial intelligence solution provider that focuses on the creation of multi-modal generative big models and application products. It offers broad services to institutional businesses and technical service providers in specific industries.
Show more investments...

Golden Gate Ventures
VC Fund · Singapore, Central Region, Singapore · 4 investments in the past 12 months

Golden Gate Ventures is a venture capital firm investing across Southeast Asia. Since 2011, the firm has launched four funds, managed US$250M AUM, and invested in 60+ companies in over 7 countries in Asia. The firm focuses on investing in technology companies driven by the rising consumer class in Southeast Asia.

Show more...

Investment focus

  • FinTech, E-Commerce, Financial Services
  • Seed, Series A, Series B
  • Singapore, Indonesia, Thailand

Portfolio highlights

  • 13o3 — 13o3 is a boutique investment firm specializing in providing tailored solutions to complex and sophisticated business challenges for discerning clientele, mainly high-profile individuals. Launched in 2013 and founded by Asfand Yar Saeed, the company operates under the
  • Locofy — Locofy provides a service that converts designs into code. Locofy.ai aims to take away the menial work of engineers without adding complexity i.e. automating 50% or more of the current workflow starting with frontend code, allowing teams to convert their designs to code and an interactive and responsive live prototype (that runs on code), withoutwriting a single line of code.
  • Yisheng — Yisheng is a digital service platform for door-to-door car washing.
Show more investments...

Sinovation Ventures
VC Fund · Beijing, Beijing, China · 17 investments in the past 12 months

Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.

Show more...

Investment focus

  • Software, Artificial Intelligence, Mobile
  • Series A, Seed, Series B
  • China, United States, Hong Kong

Portfolio highlights

  • MetaCene — MetaCene is a blockchain company that aims to create an accessible Web3 world for the masses, with a focus on player-centric entertainment.
  • Ruishi Technology — Ruishi Technology develops Myopia prevention and control medical devices.
  • True Talents For China (TTC) — True Talents For China (TTC) is a digital and intelligent professional talent service company that provides digital platforms, business platforms, data platforms, enterprise cloud services, and other services.
Show more investments...

ZhenFund
VC Fund · Beijing, Beijing, China · 14 investments in the past 12 months

ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.

Show more...

Investment focus

  • Artificial Intelligence, Software, E-Commerce
  • Series A, Seed, Series B
  • China, United States, Singapore

Portfolio highlights

  • Levinthal — Levinthal is an AI-driven protein design platform. They offer services for artificial intelligence in food safety and medical care. They offer synthetic biology, food, feed, and environmental protection.
  • U Power — U Power is an intelligent electric vehicle company that builds cars for scenarios. It aims to enable scenario owners to define cars through standardized UP super chassis and to achieve Car as a Service. The company is headquartered in Xuhui District, Shanghai, China.
  • Dark Side of the Moon — Dark Side of the Moon is an AI large-scale model company.
Show more investments...

K2VC
VC Fund · Beijing, Beijing, China · 12 investments in the past 12 months

K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.

Show more...

Investment focus

  • E-Commerce, Health Care, Software
  • Series A, Angel, Seed
  • China, United States, Japan

Portfolio highlights

  • Spatomics — Spatomics is focusing on creating a cutting-edge multi-omics tool platform for single cells.
  • Cornerstone Robotics — Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
  • Aureka Biotechnologies — Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Show more investments...

OrbiMed
VC Fund · New York, New York, United States · 38 investments in the past 12 months

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, China, Israel

Portfolio highlights

  • Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
  • Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
  • Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
Show more investments...

Sunland Fund
VC Fund · Shanghai, Shanghai, China · 6 investments in the past 12 months

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China

Portfolio highlights

  • Jiyuan Medical — Jiyuan Medical focuses on disposable gynecological endoscopes and peripheral products. Its products include disposable electronic hysteroscopes (including 4K high-definition mirrors, resectoscopes, fluoroscopes, near-infrared mirrors, and NBI mirrors), disposable gynecological minimally invasive surgical instruments, hysteroscopes Intelligentworkstations, disposable fetoscopes, and disposable mammoscopes to create an overall solution for disposable gynecological endoscopes based on disposable electronic hysteroscopes.
  • BD Gene Therapeutics — BD Gene Therapeutics is a provider of a gene-editing platform for the treatment of genetic diseases. It uses mRNA delivery technology to achieve safe and efficient delivery of gene-editing tools such as CRISPR. In addition, BD-mRNA technology has important application prospects in the fields of tumor immunity and regenerative medicine. It also usesthe fourth-generation lentiviral vector platform for all types of cells. It has developed antiviral eyedrops and others.
  • Hexin Pharmaceutical — Hexin Pharmaceutical is a developer of nuclide drugs integrating targeted diagnosis and treatment.
Show more investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 7 investments in the past 12 months

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Angel
  • China, United States

Portfolio highlights

  • Kanova — Kanova is a biopharmaceutical firm.
  • Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Show more investments...
Investors by industry
Investors by country
VC (Venture Capital) Funds in Asia by industry

Close your round

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Join 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck